Europe's new investment firm says it's on a mission to lift up the continent's 'underexploited' science
Like many, Alexandre Mouradian saw the Covid-19 pandemic as a wake-up call. More disease emergencies are coming, he said, and he wanted to do something about it.
On Monday, he launched eureKARE, a new Paris-based venture firm aiming to bridge the gap between academia and industry. And he’s landed a $60 million Series A round to get started.
“European science remains underexploited compared to countries like the US, with the gap between academia and big pharma widening over the years,” CEO Rodolphe Besserve said in a statement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.